Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Starch × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Carcinoma In Situ 1

Interventions

Specimen Handling 220 pembrolizumab 199 Magnetic Resonance Spectroscopy 180 Biopsy 134 Carboplatin 130 Cyclophosphamide 115 Nivolumab 108 Cisplatin 104 Paclitaxel 98 Radiotherapy 85 Gemcitabine 70 Bevacizumab 69 venetoclax 67 durvalumab 64 Dexamethasone 64 Oxaliplatin 57 Docetaxel 56 atezolizumab 55 Ipilimumab 55 Capecitabine 55 fludarabine 54 Rituximab 54 Fluorouracil 54 Prednisone 52 Radiation 49 olaparib 48 Etoposide 48 Radiosurgery 46 Drug Therapy 46 Cytarabine 46

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07443943 2026-03-02

AIMSS-RPS

University of Michigan Rogel Cancer Center

Phase 2 Not yet recruiting

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡